Skip to main content
. 2017 Oct 31;43(2):120–130. doi: 10.1503/jpn.170041

Table 1.

Demographic and clinical characteristics of study participants

Group; mean ± SD or no. (%)

Characteristic BD (n = 40) Control (n = 48) Statistical test Effect size p value
Age, yr 17.03 ± 1.44 15.85 ± 1.74 U = 572.5 d = 0.739 0.001
Female sex 24 (60) 25 (52) χ2 = 0.554 V = 0.079 0.46
Socioeconomic status 52.35 ± 12.38 52.98 ± 10.31 t = −0.26 d = 0.051 0.80
BD subtype
 BD-I 14 (35)
 BD-II 14 (35)
 BD-NOS 12 (30)
Waist circumference 82.15 ± 9.48 74.62 ± 6.97 U = 317 d = 0.905 0.001
Adjusted BMI 24.44 ± 4.32 21.22 ± 2.98 U = 470 d = 0.868 < 0.001
Resting systolic BP 112.68 ± 12.84 109.85 ± 17.13 t = 0.86 d = 0.187 0.40
Resting diastolic BP 68.58 ± 7.81 68.07 ± 10.00 t = 0.26 d = 0.057 0.80
Lifetime tobacco use 6 (25) 0 (0) χ2 = 4.70 V = 0.389 0.030
Lifetime comorbid diagnoses
 ADHD 17 (44) 5 (10) χ2 = 11.78 V = 0.372 0.001
 Anxiety 29 (73) 2 (4) χ2 = 43.88 V = 0.710 < 0.001
 SUD 9 (23) 0 (0) χ2 = 12.03 V = 0.370 < 0.001
 ODD 12 (30) 0 (0) χ2 = 16.67 V = 0.435 < 0.001
 CD 3 (8) 0 (0) χ2 = 3.73 V = 0.206 0.05
Family history*
 Mania/hypomania 22 (55)
 Depression 27 (68) 9 (19) χ2 = 21.45 V = 0.494 < 0.001
 Anxiety 22 (55) 9 (19) χ2 = 12.57 V = 0.378 < 0.001
 ADHD 9 (23) 1 (2) χ2 = 9.03 V = 0.320 0.003
Medications
 Second-generation antipsychotics 21 (53)
 Lithium 8 (20)
 SSRIs 11(28)
 Non-SSRI antidepressants 4 (10)
 Stimulants 9 (23)

ADHD = attention-deficit/hyperactivity disorder; BD = bipolar disorder; BMI = body mass index; BP = blood pressure; CD = conduct disorder; NOS = not otherwise specified; ODD = oppositional defiant disorder; SD = standard deviation; SSRI = selective serotonin reuptake inhibitor; SUD = substance use disorder.

*

First- or second-degree relatives.